Bian, D., Ji, S., Liu, Y., Huang, Z., Jiang, L., Liu, M., Bao, X., Yang, J., Zhou, Y., Hu, J., Sun, L., Zheng, Y., Huang, J., Liu, J., Zhu, X., Zhang, J., Zhang, L., Liu, X., He, W., Xie, D., Zhu, Y., Wu, C., Zhao, D., Duan, L., Jiang, G., Zhang, P. (2025). Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial. Nature Communications. https://doi.org/10.1038/s41467-025-58435-9